Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

XBI vs XOVR: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, XBI returned +41.2% to XOVR's −3.0%, and XBI charges 0.35% to XOVR's 1.81%.

askIQ about this page

askIQ about XBI and XOVR

Net assets: $10.3bn on Oct 27, 2026 for State Street SPDR S&P Biotech ETF, and $2.2bn on Jun 30, 2026 for ERShares Private-Public Crossover ETF.

At a glance
+41.2%
XBI total return, 1 year
−3.0%
XOVR total return, 1 year
0.35%
XBI expense ratio
1.81%
XOVR expense ratio

Pair scorecard

XBI costs 1.46 points a year less; their one-year returns differ by 44.2 points.

XBI vs XOVR: Differences, Returns & Fees
MeasureXBIXOVR
Return
Total return, 1 year+41.2%−3.0%
Drawdown
Below its all-time high8.9%, high on Feb 8, 2021
Below its high6.5%, high on Oct 5, 2026
Benchmark
What it tracksBiotechNo index, actively managed
Cost and size
Expense ratio0.35%1.81%
Net assets, XBI as of Oct 27, 2026 and XOVR as of Jun 30, 2026$10.3bn$2.2bn
Active share vs the S&P 50098%
Holdings
Holdings in common3%
Top ten holdings, share of the fund18%63.1%

Holdings in common uses holdings dated Jun 30, 2026 and Oct 27, 2026. Method

What they share

3%

By the books each fund has filed, XBI and XOVR hold 3% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Oct 27, 2026.

0 half 100%

half

3% in common

Positions both hold · largest shared weight first XBI XOVR
NATERA INC 1.82% 3.70%
EXELIXIS INC 1.64% 1.89%
Only in one fund ↓
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
SPYRE THERAPEUTICS INC 1.67%
Only in XOVR
N/A 17.73%
Nvidia Corp 9.47%
Astera Labs Inc 7.75%
Alphabet Inc 6.52%
Meta Platforms Inc 4.47%
Applovin Corp 3.95%
Robinhood Markets Inc 3.55%
Veeva Systems Inc 3.17%
Check overlap with more funds →

Side by side

XBI State Street SPDR S&P Biotech ETF XOVR ERShares Private-Public Crossover ETF
Where it sits Thematic ETF Stock ETF
Issuer State Street ERShares
What it is Biotech Actively managed
Total return, 1 year +41.2% −3.0%
Expense ratio 0.35% 1.81%
Already in the S&P 500 13.2% 43.4%
Holdings 165 32
Net assets, XBI as of Oct 27, 2026 and XOVR as of Jun 30, 2026 $10.3bn $2.2bn

XBI and XOVR on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

XOVR

XOVR is actively managed and tracks no index. Over the year to Oct 28, 2026 it returned −3.0% with distributions reinvested. The prospectus expense ratio is 1.81% a year. By its holdings filed for Jun 30, 2026, 43% of the fund by weight is stocks the S&P 500 also holds, across 32 positions, with the top ten at 63.1%. It sat 6.5% below its high of Oct 5, 2026 on Oct 28, 2026.

Questions people ask

Are XBI and XOVR in the same category?
XBI is a thematic ETF and XOVR is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, XBI or XOVR?
In the year to Oct 28, 2026, with distributions reinvested, XBI returned +41.2% and XOVR −3.0%.
Which is cheaper, XBI or XOVR?
XBI is cheaper, by 1.46 percentage points a year. That is about $146 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do XBI and XOVR overlap with the S&P 500?
By their latest filed holdings, 13% of XBI and 43% of XOVR by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, XBI against XOVR, data as of Oct 28, 2026. https://etfiq.com/compare/any/xbi-vs-xovr

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.